INS and cancer: Interestingly, on the same hand, emerging reports suggest that the expressions of insulin and IGF receptor isoforms vary according to tissue types and ligand bioavailability (70) and that there are therapeutic selective dependencies for distinct subtypes of PI3K pathway altered in cancer (71).